Niaid-VRC-research, development, and production to support ebola bispecific antibody development
Active Awarded Last action
- Contract number
- 75N91022F00015
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,431,863
Award facts
- Contract value 45% obligated
-
- $5,431,863.00 Current, with exercised options
- $12,200,856.00 Potential, with all options
- Completion date 71% complete
- Current and potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $215,847 | |
| Original award | $5,216,016 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $12.2 million delivery order contract to Leidos Biomedical Research Inc. to support research, development, and production efforts related to Ebola bispecific antibody development. As the prime contractor, Leidos Biomedical Research will perform work at its place of performance in Fort Detrick, Maryland under a cost plus fixed fee contract running from September 2022 through July 2028.
Quick answers
Who was awarded contract 75N91022F00015?
75N91022F00015 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 19, 2022.
How much is contract 75N91022F00015 worth?
The government has obligated $5,431,863 on 75N91022F00015. Its potential value, with all options, is $12,200,856.
Which agency awarded contract 75N91022F00015?
National Cancer Institute (National Institutes of Health) awarded 75N91022F00015, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract 75N91022F00015 an order under another contract?
Yes. 75N91022F00015 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91022F00015 competed?
The extent of competition for 75N91022F00015 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award